公开(公告)号：US10112946B2

公开(公告)日：2018-10-30

申请号：US14234070

申请日：2012-07-19

Applicant: Claire Louise Ambery ,  Christopher David Edwards

Inventor： Claire Louise Ambery ,  Christopher David Edwards

IPC: C07D473/28 ,  A61K9/00 ,  A61K9/12 ,  A61K31/522

Abstract: Compound (I), and pharmaceutically acceptable salts thereof, are inducers of human interferon. Certain discrete and particular dosages of Compound (I) may be particularly useful in the treatment of various disorders, for example the treatment of allergic diseases and other inflammatory conditions, for example allergic rhinitis and allergic asthma.

公开(公告)号：US20140288099A1

公开(公告)日：2014-09-25

申请号：US14234070

申请日：2012-07-19

Applicant: Claire Louise Ambery ,  Christopher David Edwards

Inventor： Claire Louise Ambery ,  Christopher David Edwards

IPC: C07D473/28

CPC classification number: C07D473/28 ,  A61K9/0043 ,  A61K9/0073 ,  A61K9/12 ,  A61K31/522

Abstract: Compound (I), and pharmaceutically acceptable salts thereof, are inducers of human interferon. Certain discrete and particular dosages of Compound (I) may be particularly useful in the treatment of various disorders, for example the treatment of allergic diseases and other inflammatory conditions, for example allergic rhinitis and allergic asthma.

Abstract translation: 化合物（I）及其药学上可接受的盐是人类干扰素的诱导剂。 化合物（I）的某些离散和特定剂量可能特别可用于治疗各种疾病，例如治疗过敏性疾病和其它炎性病症，例如过敏性鼻炎和过敏性哮喘。